Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1957 2
1959 1
1964 1
1966 2
1968 2
1969 3
1970 1
1971 5
1972 2
1973 1
1974 1
1975 4
1976 1
1977 2
1978 3
1980 4
1981 2
1982 1
1983 4
1984 6
1985 5
1986 8
1987 7
1988 6
1989 11
1990 4
1991 11
1992 10
1993 11
1994 14
1995 10
1996 19
1997 16
1998 28
1999 18
2000 23
2001 18
2002 23
2003 31
2004 42
2005 51
2006 36
2007 46
2008 55
2009 40
2010 55
2011 59
2012 76
2013 70
2014 63
2015 66
2016 63
2017 63
2018 51
2019 60
2020 68
2021 61
2022 76
2023 62
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

1,364 results

Results by year

Filters applied: . Clear all
Page 1
M6A-modified circRBM33 promotes prostate cancer progression via PDHA1-mediated mitochondrial respiration regulation and presents a potential target for ARSI therapy.
Zhong C, Long Z, Yang T, Wang S, Zhong W, Hu F, Teoh JY, Lu J, Mao X. Zhong C, et al. Int J Biol Sci. 2023 Mar 5;19(5):1543-1563. doi: 10.7150/ijbs.77133. eCollection 2023. Int J Biol Sci. 2023. PMID: 37056926 Free PMC article.
However, the biological relevance of m6A modification of circRNAs in prostate cancer (PCa) remains unclear and needs to be elucidated. Our data showed that circRBM33 was m6A-modified and was more highly expressed in PCa cells than in normal cells/tissues. ...Additionally, …
However, the biological relevance of m6A modification of circRNAs in prostate cancer (PCa) remains unclear and needs to be elucidated …
Aminooxyacetic acid hemihydrochloride leads to decreased intracellular ATP levels and altered cell cycle of prostate cancer cells by suppressing energy metabolism.
Teng H, Yang B, Su Y, Chen J, Cui L, Sun R, Zhao J, Liu Q, Qin A. Teng H, et al. Biomed Pharmacother. 2023 Nov;167:115605. doi: 10.1016/j.biopha.2023.115605. Epub 2023 Oct 4. Biomed Pharmacother. 2023. PMID: 37801901 Free article.
We previously discovered that aminooxyacetic acid hemihydrochloride (AOAA) suppressed bone resorption and osteoclast growth by decreasing adenosine triphosphate (ATP) production and limiting oxidative phosphorylation (OXPHOS). ...On the whole, our findings im …
We previously discovered that aminooxyacetic acid hemihydrochloride (AOAA) suppressed bone resorption and osteoclast growth by decreasing …
Hydrolysis of ATP, ADP, and AMP is increased in blood plasma of prostate cancer patients.
Gardani CFF, Cappellari AR, de Souza JB, da Silva BT, Engroff P, Moritz CEJ, Scholl JN, Battastini AMO, Figueiró F, Morrone FB. Gardani CFF, et al. Purinergic Signal. 2019 Mar;15(1):95-105. doi: 10.1007/s11302-018-9642-3. Epub 2019 Jan 14. Purinergic Signal. 2019. PMID: 30644036 Free PMC article.
Thus, the present study aimed to evaluate the hydrolysis of adenine nucleotides (ATP, ADP, and AMP) in the plasma blood of patients with prostate cancer. ...Therefore, we can suggest that the nucleotide hydrolysis might be attributed to soluble ecto-enzymes present …
Thus, the present study aimed to evaluate the hydrolysis of adenine nucleotides (ATP, ADP, and AMP) in the plasma blood of patients w …
Daidzein alleviates doxorubicin-induced heart failure via the SIRT3/FOXO3a signaling pathway.
Li H, Zhang M, Wang Y, Gong K, Yan T, Wang D, Meng X, Yang X, Chen Y, Han J, Duan Y, Zhang S. Li H, et al. Food Funct. 2022 Sep 22;13(18):9576-9588. doi: 10.1039/d2fo00772j. Food Funct. 2022. PMID: 36000402
Daidzein (DAI), an isoflavone found in soy foods, is widely used to treat menopausal syndrome, prostate cancer, breast cancer, heart disease, cardiovascular disease, and osteoporosis, and has anti-oxidant and anti-inflammatory properties. ...Mechanistically, DAI affects ca …
Daidzein (DAI), an isoflavone found in soy foods, is widely used to treat menopausal syndrome, prostate cancer, breast cancer, heart …
ATP-gated P2X7 receptor as a potential target for prostate cancer.
Qiao C, Tang Y, Li Q, Zhu X, Peng X, Zhao R. Qiao C, et al. Hum Cell. 2022 Sep;35(5):1346-1354. doi: 10.1007/s13577-022-00729-x. Epub 2022 Jun 3. Hum Cell. 2022. PMID: 35657562 Review.
The P2X7 receptor is an important member of purine receptor family. It is a gated ion channel with adenosine triphosphate (ATP) as the ligand, which exists in a variety of immune tissues and cells and can be involved in tumorigenesis and tumor progression. St …
The P2X7 receptor is an important member of purine receptor family. It is a gated ion channel with adenosine triphosphate ( …
Metformin and prostate cancer stem cells: a novel therapeutic target.
Mayer MJ, Klotz LH, Venkateswaran V. Mayer MJ, et al. Prostate Cancer Prostatic Dis. 2015 Dec;18(4):303-9. doi: 10.1038/pcan.2015.35. Epub 2015 Jul 28. Prostate Cancer Prostatic Dis. 2015. PMID: 26215782 Review.
Prostate cancer is the second most frequently diagnosed cancer in the world. ...There is a need for more effective therapy for advanced prostate cancer. One potential target is the cancer stem cell (CSC). ...
Prostate cancer is the second most frequently diagnosed cancer in the world. ...There is a need for more effective therapy for advanc …
Investigating the oral microbiome in retrospective and prospective cases of prostate, colon, and breast cancer.
Nearing JT, DeClercq V, Langille MGI. Nearing JT, et al. NPJ Biofilms Microbiomes. 2023 May 1;9(1):23. doi: 10.1038/s41522-023-00391-7. NPJ Biofilms Microbiomes. 2023. PMID: 37127667 Free PMC article.
To examine this, we made use of salivary samples from the Atlantic Partnership for Tomorrow's Health (PATH) project and Alberta's Tomorrow Project (ATP). Sample selection was divided into both a retrospective and prospective case control design examining prostate, b …
To examine this, we made use of salivary samples from the Atlantic Partnership for Tomorrow's Health (PATH) project and Alberta's Tomorrow P …
RAD51C-XRCC3 structure and cancer patient mutations define DNA replication roles.
Longo MA, Roy S, Chen Y, Tomaszowski KH, Arvai AS, Pepper JT, Boisvert RA, Kunnimalaiyaan S, Keshvani C, Schild D, Bacolla A, Williams GJ, Tainer JA, Schlacher K. Longo MA, et al. Nat Commun. 2023 Jul 24;14(1):4445. doi: 10.1038/s41467-023-40096-1. Nat Commun. 2023. PMID: 37488098 Free PMC article.
RAD51C is an enigmatic predisposition gene for breast, ovarian, and prostate cancer. Currently, missing structural and related functional understanding limits patient mutation interpretation to homology-directed repair (HDR) function analysis. ...Mapping of cancer patient …
RAD51C is an enigmatic predisposition gene for breast, ovarian, and prostate cancer. Currently, missing structural and related functi …
Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells.
Ghalali A, Wiklund F, Zheng H, Stenius U, Högberg J. Ghalali A, et al. Carcinogenesis. 2014 Jul;35(7):1547-55. doi: 10.1093/carcin/bgu019. Epub 2014 Jan 22. Carcinogenesis. 2014. PMID: 24451147
Interestingly, the interaction between EHBP1 and P-Rex1 was not induced by extracellular adenosine triphosphate (ATP), the endogenous P2X7 ligand, and statins counteracted invasiveness stimulated by extracellular ATP. ...Our data indicate a novel signa …
Interestingly, the interaction between EHBP1 and P-Rex1 was not induced by extracellular adenosine triphosphate (ATP), …
RNA Interference against ATP as a Gene Therapy Approach for Prostate Cancer.
Chen S, Ma J, Xiao Y, Zhou D, He P, Chen Y, Zheng X, Lin H, Qiu F, Yuan Y, Zhong J, Li X, Pan X, Fang Z, Wang C. Chen S, et al. Mol Pharm. 2023 Oct 2;20(10):5214-5225. doi: 10.1021/acs.molpharmaceut.3c00587. Epub 2023 Sep 21. Mol Pharm. 2023. PMID: 37733628
Herein, we developed an RNA interference (RNAi) method against adenosine triphosphate (ATP) by constructing an interfering plasmid-expressing ATP-binding RNA aptamer, which notably inhibited the growth of prostate cancer cells through diminishin …
Herein, we developed an RNA interference (RNAi) method against adenosine triphosphate (ATP) by constructing an interfer …
1,364 results